<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Meprinα, an astacin-type metalloprotease is overexpressed in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cells and is secreted in a non-polarized fashion, leading to the accumulation of meprinα in the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> stroma </plain></SENT>
<SENT sid="1" pm="."><plain>The transition from <z:mpath ids='MPATH_458'>normal</z:mpath> colonocytes to <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> correlates with increased meprinα activity at <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumor</z:e> sites </plain></SENT>
<SENT sid="2" pm="."><plain>A role for meprinα in invasion and metastatic dissemination is supported by its pro-angiogenic and pro-migratory activity </plain></SENT>
<SENT sid="3" pm="."><plain>In the present study, we provide evidence for a meprinα-mediated transactivation of the EGFR signaling pathway and suggest that this mechanism is involved in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> progression </plain></SENT>
<SENT sid="4" pm="."><plain>Using alkaline phosphatase-tagged EGFR ligands and an ELISA assay, we demonstrate that meprinα is capable of shedding epidermal growth factor (EGF) and transforming growth factor-α (TGFα) from the plasma membrane </plain></SENT>
<SENT sid="5" pm="."><plain>Shedding was abrogated using actinonin, an inhibitor for meprinα </plain></SENT>
<SENT sid="6" pm="."><plain>The physiological effects of meprinα-mediated shedding of EGF and TGFα were investigated with human colorectal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> cells (Caco-2) </plain></SENT>
<SENT sid="7" pm="."><plain>Proteolytically active meprinα leads to an increase in EGFR and ERK1/2 phosphorylation and subsequently enhances cell proliferation and migration </plain></SENT>
<SENT sid="8" pm="."><plain>In conclusion, the implication of meprinα in the EGFR/MAPK signaling pathway indicates a role of meprinα in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> progression </plain></SENT>
</text></document>